Loading…
Loading…

Operator guide
A recovery studio's website, booking page and service menu are advertising, and the standard a health claim in advertising has to meet is published, not a matter of taste. The FTC's Health Products Compliance Guidance requires competent and reliable scientific evidence behind a health claim, meaning tests and research conducted and evaluated objectively by qualified experts and generally accepted in the profession. Almost everything a studio genuinely wants to say can be said without asserting an outcome at all, and the method for rewriting copy that way is the useful part of this subject. None of this is legal advice.
Every sentence a studio publishes about what it sells is advertising: the service menu, the booking page descriptions, the window vinyl, the intake email, the caption under a photograph of the plunge tub, the sentence a staff member says at the desk. The category the copy sits in does not change the standard applied to it, and the standard for a health claim is written down. The FTC's Health Products Compliance Guidance describes it as competent and reliable scientific evidence: tests, analyses and research conducted and evaluated objectively by qualified experts[1], using procedures generally accepted in the profession to yield accurate and reliable results.
That definition is stricter than it sounds when read next to a typical recovery menu. Randomized controlled trials are the standard form the guidance points to. Animal studies on their own do not qualify. Laboratory and in-vitro work on its own does not qualify. Consumer anecdotes, practitioner observations and preliminary research do not qualify, and the guidance is direct that numerous flawed studies do not add up to adequate substantiation. A studio that assembled a folder of links to support a claim on its homepage has usually assembled exactly the material the guidance says is not enough.
The good news is structural. The information a prospective member actually needs before booking is almost entirely factual: what the room is, how long the session runs, whether it is staffed, what to bring, who should check with a clinician first, and what a first visit feels like. None of that requires a substantiated health claim, and copy built from it converts better than copy built from adjectives. It is not legal advice, and a lawyer who reviews consumer-protection matters in your state should see anything you are unsure about.
Substantiation is not a footnote you add after the fact. Under the FTC's guidance the support has to exist at the time the claim is made, and it has to match the claim being made: a specific, strong claim needs stronger support than a general one, and a claim about a health outcome sits at the demanding end of that range. The relevant question for a studio is not whether some research exists on a modality. It is whether the body of evidence, judged by qualified experts, supports the particular thing your sentence tells the reader will happen to them.
Recovery modalities are an awkward fit for that test, and pretending otherwise is where operators get into trouble. Several of them have real research behind them that is small, short, narrow in population, and focused on outcomes like soreness or perceived recovery instead of on the sweeping benefits marketing copy tends to reach for. Describing that research accurately, with its size and its limits, is a legitimate thing to do. Converting it into a promise addressed to the reader is a different act, and the second one is the claim that needs substantiation the first one does not.
The single most useful distinction for a service menu is between what a modality IS and what it DOES to a body. A description of the service is a factual account of a thing you sell: the equipment, the temperature you hold, the session length, the staffing, the sequence, the room. An outcome assertion tells the reader what will happen inside them as a result.
The first is verifiable by anyone who walks in. The second is a health claim, and it carries the evidentiary burden above.
The line is not drawn by vocabulary alone, which is why keyword-scrubbing your website does not solve this. The FTC reads an advertisement for the claims it conveys overall, including the ones it implies. A factual sentence placed under a headline, next to a photograph of an athlete and above a testimonial about recovering from an injury, can convey an outcome claim that none of its individual sentences state. Read your page the way a first-time visitor reads it, in one pass, and ask what they would tell a friend it promised.
Two habits do most of the work. First, put the subject of the sentence back on the service rather than on the reader's body: the room does something, rather than the reader's inflammation doing something. Second, when you genuinely want to reference research, reference it as research, with its shape visible: who was studied, how many, over how long, and what the study measured. A sentence that describes a small trial in athletes is a different kind of statement from a sentence that tells a member with a chronic condition what will happen to them.
The exercise is to take each service on the menu and rewrite its description so that every sentence would still be true if the modality turned out to do nothing at all. That sounds like a loss of persuasive power and usually is not, because the replacement sentences are more concrete than the ones they replace and answer questions a buyer actually has. The pairs below show the shape of the move; none of them is copy to paste.
A studio cannot outsource a claim to a customer. Under the FTC's Endorsement Guides an endorsement must reflect the endorser's genuine opinion, and it cannot convey a claim that the advertiser could not lawfully make itself[3]. A member's five-star post saying a modality resolved a medical condition is, once it is on your homepage or your story highlight, an assertion by you, and it needs the same substantiation your own sentence would need. This is the point where reputation work and claims compliance stop being separate subjects.
The second rule that catches studios is the exceptional-results disclosure. Where a testimonial describes results that are not what people generally get, the Endorsement Guides require disclosing what consumers can generally expect. In practice this means the most dramatic story you have collected is the hardest one to publish, because you are unlikely to hold the data that would let you describe a typical result at all. A quieter testimonial about the experience of coming in, the staff, and the routine carries none of that burden.
Material connections have to be disclosed as well, wherever a significant minority of consumers would not expect them. An employment relationship has to be disclosed in the post itself rather than tucked into a profile bio[3], which matters directly for a studio whose staff post about the floor they work on. The Consumer Reviews and Testimonials Rule goes further and prohibits insider reviews by employees, relatives or agents without a clear and conspicuous disclosure[4] of the connection, along with fake or false testimonials outright.
Marketing that describes a device as doing something therapeutic is not only an advertising question. FDA regulates devices by intended use, and the intended use is established in large part by what the marketing says. FDA's draft guidance on photobiomodulation devices, which it also calls low level light therapy devices, places them in Class II under specific regulations while noting that some light-emitting products intended only for general wellness use and presenting low risk fall outside its scope. The operator-relevant reading is that a therapeutic claim is precisely what pulls a light device into device regulation. That guidance is a draft and is non-binding, on FDA as well as on you, so it indicates thinking rather than settling the question.
The sharpest illustration on the public record is an FDA warning letter to a manufacturer of LED low-level-light devices, which were marketed for neuropathy, fat loss, cellulite, scars, wrinkles, inflammation and pain while the company's website described them as FDA approved. FDA found the devices adulterated, because there was no premarket approval or valid clearance for the marketed uses[5], and misbranded, and stated that the FDA approved claim was misleading when only clearances for different uses existed. Every element of that is available to a studio to repeat by accident: a real device, a real clearance, and copy that describes uses the clearance never covered.
Two things follow for a floor. A clearance covers the indications it names and nothing else, so the correct thing to know about your equipment is not whether it is cleared but what it is cleared FOR, which is a question your vendor should answer in writing. And a vendor's marketing pack is not a safe harbour: when you publish the manufacturer's sentence on your own site, it is your claim. FDA's Class II special controls guidance for low level laser systems used aesthetically names the risks such devices carry, including ocular injury, electrical shock, unintended cell damage and use error[7], and notes that clinical data may be required where an indication differs from a legally marketed comparable system.
Recurring memberships bring a second body of rules into the same page. The live legal hook is ROSCA, a statute, and section 8403 sets three requirements for an online negative-option charge: text that clearly and conspicuously discloses all material terms before you take billing information, express informed consent obtained before the account is charged, and simple mechanisms for the member to stop the recurring charges[8]. All three apply to a studio selling a monthly membership through its own checkout, and the third is the one operator checklists most often drop.
A separate 2024 FTC rule, often called click to cancel, was vacated and is not in force, and the Commission has returned to an advance notice of proposed rulemaking on negative-option marketing[9]. Be precise about what the vacatur actually removed, because it is narrower than the reporting suggests. What that rule added on top of the statute was proof of consent retained for at least three years and cancellation offered in the same medium the member used to join. Those two are the parts that are not current law, and both are worth adopting as your operating standard anyway. The duty to give a member a simple way to stop the charges is not one of them: it is in the statute, and it survived the rule.
A studio that cleans up its website has fixed the least frequently read surface it owns. Claims enter through every channel where somebody describes the service, and most of those channels have no review step at all: the services list on a business profile, a directory listing description, an Instagram caption written on a phone, a printed card in the lobby, the sentence a new hire improvises when a member asks what the plunge does, an automated email that has been sending unchanged for two years.
The fix is inventory, not vigilance. Write down every surface where your studio describes what it sells, name an owner for each one, and put the same rewritten service descriptions everywhere so that the compliant version is also the convenient version. Staff scripts belong in that inventory and are usually the largest exposure, because a verbal claim is unreviewable, unlogged, and made by the person the member trusts most.
A free Praxium directory listing is one of those surfaces: it carries a studio profile into city and modality searches, and the description you supply there is advertising in exactly the way your own site is. The optional protocol layer is another, one step further back: the goal-based plans it builds from a studio's own menu are internal operating documents until one is shown to a member, and at that moment the same rule reaches them.
Compliance work decays because copy is written by many people at different times and nobody owns the sum of it. The maintainable version is a short, boring loop: a substantiation file, a claim register, and a review that happens on a calendar, not after a complaint. The substantiation file holds, for every claim you have decided to make, the specific evidence you are relying on and the date you assessed it. If a claim has no entry, it either gets support or gets rewritten into a description.
Give one person sign-off on new copy, and give the whole team a one-page rule they can apply without asking: describe the session, not the outcome, and route anything that names a condition to the person with sign-off. Re-read the register when you add a modality, when you buy a device, when a vendor sends new marketing material, and when a piece of research on one of your modalities becomes widely discussed, because that is exactly when someone will want to add a sentence to the homepage.
The last piece is what to do with the claims you decide you cannot make. Do not simply delete them and leave a thinner page. Replace them with the operational detail that was missing anyway: who the session is not appropriate for, what happens on a first visit, how the sequence is built, what the staff do. Pages rewritten that way tend to answer more of the questions a buyer actually has, which is the reason to do this beyond the enforcement risk.
For studio operators
Get listed on Praxium and turn your menu into goal-based protocols your team runs every shift — built on the modalities you already offer.
Questions
That sentence is a health claim, so it needs what the FTC calls competent and reliable scientific evidence, which consumer anecdotes, staff observation, animal work alone and preliminary studies do not meet, which is why the safer and usually more useful sentence describes the service instead: the temperature, the session length, the staffing and what a first visit involves.
The FTC's Health Products Compliance Guidance defines it as tests, analyses and research conducted and evaluated objectively by qualified people, using procedures generally accepted in the relevant profession to produce accurate and reliable results. Randomized controlled trials are the standard form for a health claim. The support has to exist when the claim is made and has to match the claim's strength and specificity. Explicitly outside the standard: anecdotes, practitioner observations, animal studies on their own, in-vitro work on its own, and preliminary research presented as settled.
Yes, within limits that are easy to trip. An endorsement must be the endorser's genuine opinion and cannot convey a claim you could not lawfully make yourself, so a review asserting a medical outcome becomes your unsubstantiated claim once you publish it. Where a testimonial describes exceptional results, the FTC Endorsement Guides require disclosing what consumers can generally expect. Material connections have to be disclosed, and an employment relationship has to appear in the post itself rather than in a profile bio. Fabricated testimonials and undisclosed insider reviews are prohibited outright.
Treating clearance and approval as the same word is a documented violation. In an FDA warning letter on the public record, a company marketing LED low-level-light devices for neuropathy, fat loss, cellulite, scars, wrinkles, inflammation and pain described them on its website as FDA approved. FDA found the devices adulterated, because no premarket approval or valid clearance existed for the marketed uses, and misbranded, and said the FDA approved claim was misleading when only clearances for different uses existed. Ask your vendor in writing what the exact model is cleared for, and keep your copy inside that.
Write sentences that would still be true if the modality did nothing. Describe the equipment, the temperature or setting you hold, the session length, whether staff are present, the sequence, what to bring, and what a first visit feels like. Put the subject of the sentence on the service rather than on the reader's body. If you want to reference research, describe the research as research, with its size, population and measured outcome visible, instead of converting it into a promise addressed to the reader. Then read the whole page in one pass and ask what it implies overall.
No, but do not read that as permission to make cancelling difficult. The FTC's 2024 negative-option rule was vacated and is not in force, and the Commission has returned to an advance notice of proposed rulemaking on negative-option marketing. ROSCA is a statute and still applies: section 8403 requires material terms disclosed before you take billing information, express informed consent before the charge, and simple mechanisms for the member to stop the recurring charges. What the vacatur removed is the rule's two additions, same-medium cancellation and proof of consent retained for at least three years. Those remain defensible practice rather than current law. The simple-mechanism duty is current law.
Usually nobody, which is why verbal claims are the largest unmanaged exposure a studio has: a member asking what a modality does gets an unrecorded answer from the person they trust most in the building. Write a short script per modality from the same description-not-outcome rewrite you used on the website, put it in onboarding, and give everyone one rule they can apply unaided: describe the session, and route anything that names a condition to whoever holds copy sign-off.
See how Praxium helps studios and recovery brands turn complex choices into clear protocols.